Search Results - "Randall, H.B."

OPTN/SRTR 2016 Annual Data Report: Economics by Schnitzler, M. A., Skeans, M. A., Axelrod, D. A., Lentine, K. L., Randall, H. B., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…Medicare costs vary for solid organ transplant recipients by outcome: survival with graft function, survival with graft failure, and death. Average per‐person…”
Get full text

Ethnic and Gender Related Differences in the Risk of End‐Stage Renal Disease After Living Kidney Donation by Cherikh, W. S., Young, C. J., Kramer, B. F., Taranto, S. E., Randall, H. B., Fan, P.‐Y.

“…There is limited data pertaining to the risk of End Stage Renal Disease (ESRD) after living kidney donation. The Organ Procurement and Transplantation Network…”
Get full text

OPTN/SRTR 2019 Annual Data Report: Econ by Schnitzler, M.A., Miller, J., Skeans, M.A., Axelrod, D.A., Lentine, K.L., Randall, H.B., Snyder, J.J., Israni, A.K., Kasiske, B.L.

“…Resource utilization metrics vary widely across solid organ transplant modalities. Average length of stay (LOS) for kidney transplant has declined by 15.1%,…”
Get full text

Economics by Schnitzler, M.A., Valapour, M., Skeans, M.A., Axelrod, D.A., Lentine, K.L., Randall, H.B., Snyder, J.J., Israni, A.K., Kasiske, B.L.

Get full text

Access and Outcomes Among Minority Transplant Patients, 1999–2008, with a Focus on Determinants of Kidney Graft Survival by Fan, P.‐Y., Ashby, V. B., Fuller, D. S., Boulware, L. E., Kao, A., Norman, S. P., Randall, H. B., Young, C., Kalbfleisch, J. D., Leichtman, A. B.

“…Coincident with an increasing national interest in equitable health care, a number of studies have described disparities in access to solid organ…”
Get full text

OPTN/SRTR 2015 Annual Data Report: Economics by Schnitzler, M. A., Skeans, M. A., Axelrod, D. A., Lentine, K. L., Randall, H. B., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…While the costs to Medicare of solid organ transplants are varied and considerable, the total Medicare expenditure of $4.4 billion for solid organ transplant…”
Get full text

Sirolimus Conversion After Liver Transplantation: Improvement in Measured Glomerular Filtration Rate After 2 Years by Sanchez, E.Q., Martin, A.P., Ikegami, T., Uemura, T., Narasimhan, G., Goldstein, R.M., Levy, M.F., Chinnakotla, S., Dawson, S., Randall, H.B., Saracino, G., Klintmaim, G.B.

“…We reviewed our prospectively maintained database of 2005 liver transplantations. Therapy was either started de novo or converted from calcineurin inhibitors…”
Get full text

Liver and kidney transplantation for polycystic liver and kidneyrenal function and outcome by Ueno, T, Barri, Y.M, Netto, G.J, Ma, Onaca, N, Sanchez, E.Q, Chinnakotla, S, Randall, H.B, Dawson, S, Levy, M.F, Goldstein, R.M, Klintmalm, G.B

Get full text

MELD Scores Do Not Predict Patient Morbidity While on the Liver Transplant Waiting List by Cowling, T., Jennings, L.W., Goldstein, R.M., Sanchez, E.Q., Chinnakotla, S., Dawson, S., Randall, H.B., Klintmalm, G.B., Levy, M.F.

“…The goals of this study were to assess waitlist morbidity in terms of the frequency of health care services utilized by patients while on the liver transplant…”
Get full text